Templeton & Phillips Capital Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-451
Closed -$213K 54
2026
Q1
$213K Hold
451
0.17% 49
2025
Q4
$211K Buy
+451
New +$209K 0.14% 39
2025
Q1
Sell
-4,040
Closed -$1.21M 53
2024
Q4
$1.21M Sell
4,040
-98
-2% -$34.2K 0.96% 21
2024
Q3
$1.68M Buy
4,138
+157
+4% +$57.5K 1.31% 17
2024
Q2
$1.28M Buy
3,981
+57
+1% +$18.5K 1.13% 14
2024
Q1
$1.31M Buy
3,924
+142
+4% +$43.4K 1.21% 12
2023
Q4
$1.02M Buy
+3,782
New +$935K 1.04% 12

Other funds holding HCA

Templeton & Phillips Capital Management's HCA Position: Q2 2026 in Review

Templeton & Phillips Capital Management sold out of HCA Healthcare (HCA) in Q2 2026, closing a stake of 451 shares — an estimated $213K sold.

Templeton & Phillips Capital Management first reported a position in HCA in Q4 2023 and held it in 7 quarters. The position peaked at $1.68M in Q3 2024. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Templeton & Phillips Capital Management reported no remaining HCA Healthcare position as of Q2 2026 after selling out during the quarter.
  • Templeton & Phillips Capital Management sold 451 HCA Healthcare shares in Q2 2026, an estimated $213K.
  • Templeton & Phillips Capital Management first reported a position in HCA Healthcare in Q4 2023 and held it in 7 quarters.
  • Templeton & Phillips Capital Management's HCA Healthcare position peaked at $1.68M in Q3 2024.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Templeton & Phillips Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.